UCLouvain
" Production of SARS-Cov-2 glycoproteins in glyco-engineered plant suspension cells to obtain homogenous and predefined N-glycosylation profiles, characterize their binding and/or produce vaccine. "
Funding: Own funding and WALInnov
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it. UCLouvain/LIBST